{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:59:09Z","timestamp":1779890349737,"version":"3.53.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K10508"],"award-info":[{"award-number":["20K10508"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.anl.2021.06.005","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T02:42:47Z","timestamp":1625280167000},"page":"1083-1087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term efficacy of weekly paclitaxel therapy in unresectable primary squamous cell carcinoma of the thyroid"],"prefix":"10.1016","volume":"49","author":[{"given":"Sho","family":"Iwaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michi","family":"Sawabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Matoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Oguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Murashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Minohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukazu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tsuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.anl.2021.06.005_bib0001","doi-asserted-by":"crossref","first-page":"683","DOI":"10.21037\/gs.2019.11.07","article-title":"Treatment optimization and prognostic considerations for primary squamous cell carcinoma of the thyroid","volume":"8","author":"Wang","year":"2019","journal-title":"Gland Surg"},{"issue":"9","key":"10.1016\/j.anl.2021.06.005_bib0002","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1507\/endocrj.EJ12-0174","article-title":"Clinical trial of weekly paclitaxel chemotherapy for papillary thyroid carcinoma with squamous cell carcinoma component","volume":"59","author":"Ito","year":"2012","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.anl.2021.06.005_bib0003","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.anl.2017.07.009","article-title":"The treatment and outcome analysis of primary squamous cell carcinoma of the thyroid","volume":"45","author":"Yasumatsu","year":"2018","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"10.1016\/j.anl.2021.06.005_bib0004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/thy.2009.0115","article-title":"Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma","volume":"20","author":"Higashiyama","year":"2010","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.anl.2021.06.005_bib0005","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1089\/thy.2016.0072","article-title":"The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study","volume":"26","author":"Onoda","year":"2016","journal-title":"Thyroid."},{"key":"10.1016\/j.anl.2021.06.005_bib0006","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fonc.2017.00025","article-title":"Lenvatinib for Anaplastic Thyroid Cancer","volume":"7","author":"Tahara","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.anl.2021.06.005_bib0007","article-title":"Japanese Guidelines for Treatment of Thyroid Tumors 2018","volume":"35","author":"Okamoto","year":"2018","journal-title":"Ofiicial Journal of the Japan Association of Endocrine Surgeons and the Japanese Society of Thyroid Surgery"},{"issue":"3","key":"10.1016\/j.anl.2021.06.005_bib0008","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00280-010-1550-3","article-title":"Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer","volume":"68","author":"Tahara","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"182","key":"10.1016\/j.anl.2021.06.005_bib0009","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/bjs.18004318203","article-title":"Squamous-cell cysts of the thyroid with special reference to the aetiology of squamous epithelium in the human thyroid","volume":"43","author":"Goldberg","year":"1956","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.anl.2021.06.005_bib0010","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hed.2880160615","article-title":"Squamous cell carcinoma arising in Hashimoto's thyroiditis","volume":"16","author":"Chaudhary","year":"1994","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.anl.2021.06.005_bib0011","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/BF03345109","article-title":"Diffuse sclerosing variant of papillary thyroid carcinoma with primary squamous cell carcinoma","volume":"25","author":"Kebapci","year":"2002","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.anl.2021.06.005_bib0012","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000490410","article-title":"Immunohistochemical Features of Primary Pure Squamous Cell Carcinoma in the Thyroid: An Autopsy Case","volume":"11","author":"Koyama","year":"2018","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.anl.2021.06.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/638747","article-title":"Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models","volume":"2014","author":"Tohyama","year":"2014","journal-title":"J Thyroid Res"},{"issue":"1","key":"10.1016\/j.anl.2021.06.005_bib0014","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00001813-200301000-00003","article-title":"Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly","volume":"14","author":"Wang","year":"2003","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.anl.2021.06.005_bib0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/13102818.2014.909151","article-title":"VEGF expression, microvessel density and dendritic cell decrease in thyroid cancer","volume":"28","author":"Gulubova","year":"2014","journal-title":"Biotechnol Biotechnol Equip"},{"key":"10.1016\/j.anl.2021.06.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217143","article-title":"Primary squamous cell carcinoma of the thyroid with complete response to radical radiotherapy and concurrent cisplatin-based chemotherapy","volume":"2017","author":"Del Rosario","year":"2017","journal-title":"BMJ Case Rep"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814621001905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814621001905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:39:39Z","timestamp":1759952379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814621001905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0385814621001905"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2021.06.005","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term efficacy of weekly paclitaxel therapy in unresectable primary squamous cell carcinoma of the thyroid","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2021.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}